Diffuse Large B-cell Lymphoma (combination with rituximab-gemcitabine-dexamethasone-platinum (R-GDP)) | XPORT-DLBCL-030

Rights

Expected to start in 2020.

Phase IPhase IIPhase III
Phase I
Phase II
Phase III